BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1019 related articles for article (PubMed ID: 21777618)

  • 1. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
    Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
    Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concepts in the pathogenesis of Sjögren's syndrome.
    Delaleu N; Jonsson MV; Appel S; Jonsson R
    Rheum Dis Clin North Am; 2008 Nov; 34(4):833-45, vii. PubMed ID: 18984407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
    Nordmark G; Alm GV; Rönnblom L
    Nat Clin Pract Rheumatol; 2006 May; 2(5):262-9. PubMed ID: 16932699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis and diagnosis of Sjögren's syndrome].
    Witte T
    Z Rheumatol; 2010 Feb; 69(1):50-6. PubMed ID: 20012975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune response and target autoantigens in Sjogren's syndrome.
    Routsias JG; Tzioufas AG
    Eur J Clin Invest; 2010 Nov; 40(11):1026-36. PubMed ID: 20629708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of Sjögren's syndrome.
    García-Carrasco M; Fuentes-Alexandro S; Escárcega RO; Salgado G; Riebeling C; Cervera R
    Arch Med Res; 2006 Nov; 37(8):921-32. PubMed ID: 17045106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.
    Scofield RH; Asfa S; Obeso D; Jonsson R; Kurien BT
    J Immunol; 2005 Dec; 175(12):8409-14. PubMed ID: 16339583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253.
    Lisi S; Sisto M; Soleti R; Saponaro C; Scagliusi P; D'Amore M; Saccia M; Maffione AB; Mitolo V
    J Oral Pathol Med; 2007 Oct; 36(9):511-23. PubMed ID: 17850433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dendritic cells in Sjögren's syndrome.
    Vogelsang P; Jonsson MV; Dalvin ST; Appel S
    Scand J Immunol; 2006 Sep; 64(3):219-26. PubMed ID: 16918690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
    Fox PC
    Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs).
    Tzioufas AG; Hantoumi I; Polihronis M; Xanthou G; Moutsopoulos HM
    J Autoimmun; 1999 Dec; 13(4):429-34. PubMed ID: 10585759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
    Avouac J; Sordet C; Depinay C; Ardizonne M; Vacher-Lavenu MC; Sibilia J; Kahan A; Allanore Y
    Arthritis Rheum; 2006 Jul; 54(7):2243-9. PubMed ID: 16802363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis.
    Gordon TP; Bolstad AI; Rischmueller M; Jonsson R; Waterman SA
    Autoimmunity; 2001; 34(2):123-32. PubMed ID: 11905842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sjögren's syndrome. Current aspects from a rheumatological point of view].
    Tomiak C; Dörner T
    Z Rheumatol; 2006 Oct; 65(6):505-17; quiz 518-9. PubMed ID: 17004051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistopathology of Sjögren's syndrome.
    Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P
    Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathology of Sjögren's syndrome.
    Tapinos NI; Polihronis M; Tzioufas AG; Skopouli FN
    Ann Med Interne (Paris); 1998 Feb; 149(1):17-24. PubMed ID: 11490512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
    Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
    Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination between Sjögren's and non-Sjögren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens.
    Chen KS; Jiang MC; Li CJ; Liu OK; Tsai CS
    J Int Med Res; 2009; 37(4):1088-96. PubMed ID: 19761691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.